alexa The Prognostic Value Of HER2 Oncogene Expression In Human Cutaneous Squamous Cell Carcinoma | 61888
ISSN: 2155-9554

Journal of Clinical & Experimental Dermatology Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

11th Global Dermatologists Congress

Lina Alyousif, Ola Omran and Nora Alyousif
Qassim University, KSA
Posters & Accepted Abstracts: J Clin Exp Dermatol Res
DOI: 10.4172/2155-9554.C1.045
Abstract
Cutaneous squamous cell carcinoma (SCC) accounts for 20% of all dermatologic malignancies and has been defined as a proliferation of keratinocytes with potential for local and metastatic disease. HER2, a member of the Erb family of transmembrane receptor tyrosine kinases (RTK), is responsible for communicating extracellular signals to the nucleus and is implicated in tumorgenesis in several malignancies with potentially poor outcome. To date, the expression of HER2 has not been evaluated in primary cutaneous squamous cell carcinoma (SCC). This study was carried out with cooperation of Pathology Department, King Fahd Specialist Hospital, Buraidah and other hospitals in Qassim region. The study was conducted on about 40 skin specimens from patients with non melanoma skin cancer (squamous cell carcinoma) diagnosed and confirmed by biopsy. Immunohistochemical analysis for HER2 was carried out on formalin, fixed-paraffin embedded sections of skin tissues using avidin biotin peroxidase method. The age and sex of the patients, the main complaints, the clinical presentations, the tumor size and sites were recorded and analyzed. In this study, nearly all normal stratified squamous epithelium of the skin were negative, whereas cases of SCC showed positivity to HER2. HER2 expression was observed in approximately 70% of SCC cases. There was statistically significant correlation between HER2 expression histologic grade, lymph node metastasis and distant metastasis (P=0.006, 0.043, 0.009, respectively). HER2 overexpression was initially seen to be present in of breast cancer patients and more recently in a similar percentage of stomach and esophagogastric junction tumors. Previous study showed HER2 to be expressed only in 25% of metastatic SCC of the skin. To date, however, HER2 has not been evaluated in primary cutaneous SCC. There are significant clinical implications associated with the expression of this receptor; each is an independent prognostic indicator of poor outcome. In this study, 40 cases of primary cutaneous SCC were evaluated for the expression of HER2. IHC demonstrated (28/40) 70% immunoreactivity for HER2. Though a limited series, our results suggest that HER2 are overexpressed in SCC. Our findings indicate that metastatic potential of cutaneous SCC are cognate with the association of increased HER2 expression inferring a worse prognosis and greater metastatic potential. Further studies are needed to examine the expression of HER2 in the different subtypes of primary and metastatic SCC. In conclusion, we found that HER2 expression in cutaneous SCC correlated strongly with a well established negative prognostic marker. HER2 expression correlated with high tumor grade, lymph node, and distant metastasis, which indicates that HER2 can be used as an independent prognostic marker indicative of poor prognosis and a probable target in the development of novel therapies. Thus, we recommend that HER2 be routinely added as a new negative prognostic marker in all cutaneous squamous cell carcinoma patients.
Biography

Lina Alyousif is a Intern doctor , MBBS at Qassim University , KSA and head of medical student's club. She is Interested in Dermatopathology and Dermatology researches.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version